Showing results (131-140 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|February 25, 2022
Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancerShuai Liu, Ruikun Li, Qiufang Liu, et al.Cancer Biomarkers : Section a of Disease Markers|February 25, 2022
Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancerInas Elsayed, Nazik Elsayed, Qiushi Feng, et al.Cancer Biomarkers : Section a of Disease Markers|February 25, 2022
Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography imagesTouseef Ahmad Qureshi, Srinivas Gaddam, Ashley Max Wachsman, et al.Cancer Biomarkers : Section a of Disease Markers|September 2, 2025
PDCD2L overexpression represents an unfavorable prognostic marker and its inhibition shows promising therapeutic potential for gastric cancerDing-Ping Sun, Chun-Chao Chang, Hsuan-Yi Huang, et al.Cancer Biomarkers : Section a of Disease Markers|September 5, 2009
Role of BRCA1, HSD17B1 and HSD17B2 methylation in breast cancer tissueV Bhavani, M Srinivasulu, Y R Ahuja, et al.Cancer Biomarkers : Section a of Disease Markers|May 2, 2009
Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody responseSanjeev Shukla, Atul Pranay, Anil K D'Cruz, et al.Cancer Biomarkers : Section a of Disease Markers|May 2, 2009
Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applicationsGregory LeeCancer Biomarkers : Section a of Disease Markers|May 2, 2009
Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosityHeather D Kissel, Patricia C Galipeau, Xiaohong Li, et al.Cancer Biomarkers : Section a of Disease Markers|May 6, 2009
Nanoparticles in rectal cancer imagingDow-Mu Koh, Gina Brown, David J CollinsCancer Biomarkers : Section a of Disease Markers|May 6, 2009
Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticlesTina Islam, Lee JosephsonPageof 192